Physician profile
Aaron J Figler
NPI 1235187329
$2,076.49
in general payments reported to CMS, 2019-2025
13 companies · $514 in 2025
The $514 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $266 · 2023: $135 · 2024: $725 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241 · Entertainment: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.04 |
| Entertainment | $133.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $353.61 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $239.32 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $234.49 | 2024-2025 | Vevye |
| Optos, INC. | $176.44 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $155.70 | 2025 | Infuse |
| Shire North American Group INC | $137.12 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.03 | 2020 | |
| Alcon Vision LLC | $135.25 | 2019-2023 | Precision 1 |
| Dompe US, INC. | $121.81 | 2023 | Oxervate |
| Maculogix, INC. | $117.92 | 2020 | |
| Sun Pharmaceutical Industries INC. | $113.40 | 2024 | |
| Sight Sciences, INC. | $111.75 | 2024 | Omni Surgical System |
| Carl Zeiss Meditec, INC. | $43.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Figler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.